
ExpreS2ion Biotech Investor Relations Material
Latest events

Q2 2025
ExpreS2ion Biotech
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from ExpreS2ion Biotech Holding
Access all reports
ExpreS2ion Biotech Holding AB (publ), through its subsidiary, ExpreS2 ion Biotechnologies ApS, develops, produces, and delivers therapeutics or diagnostic proteins in Denmark and internationally. The company uses its expression system technology to offer services that include cell line development, screening of cell bank clones developed in the clients' host cell line of interest, analytical services comprising host cell line development, clone screening and base media optimization, process scale-up and GMP manufacturing. It also manufactures and distributes therapeutic proteins based on prokaryotic and eukaryotic expression systems using the GalXC protein expression system to EU/US chemical and health companies.
Key slides for ExpreS2ion Biotech Holding


Biostock Life Science Summit Presentation
ExpreS2ion Biotech Holding


Biostock Life Science Summit Presentation
ExpreS2ion Biotech Holding
Latest articles
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
)
The Dilemma That Brought Down Kodak
Kodak helped invent digital photography but failed to embrace it. How the innovator's dilemma turned an icon into its own most famous casualty.
21 Aug 2025
)
Maziar Mike Doustdar: Novo Nordisk's New CEO
A portrait of the pharmaceutical giant's new CEO, who assumes the position at a critical time for the company in its competition with Eli Lilly.
12 Aug 2025
Ticker symbol
EXPRS2
Country
🇸🇪 Sweden